MedTrace Logo

Search for Biomarkers of Neurodegenerative Diseases in Idiopathic REM Sleep Behavior Disorder

NCT04048603 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 182

Last updated 2021-08-06

No results posted yet for this study

Summary

This study is a prospective study with a mean of 7-year follow-up interval, aims to monitor the progression of α-synucleinopathy neurodegeneration by the evolution of prodromal markers and development of clinical disorders in patients with idiopathic REM Sleep Behavior Disorder (iRBD) and healthy controls.

Conditions

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Jihui Zhang, PhD · Chinese University of Hong Kong

  • Yun Kwok Wing, MBChB · Chinese University of Hong Kong

  • Yaping Liu, PhD · Chinese University of Hong Kong

  • Siu Ping Lam, MBChB · Chinese University of Hong Kong

  • Shirley Xin Li, PhD · The University of Hong Kong

  • Vincent Chung Tong Mok, MBChB · Chinese University of Hong Kong

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-15
Primary Completion
2022-03-31
Completion
2022-10-01

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04048603 on ClinicalTrials.gov